These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
125 related items for PubMed ID: 9474240
1. Antiproliferative activity of colchicine analogues on MDR-positive and MDR-negative human cancer cell lines. De Vincenzo R, Scambia G, Ferlini C, Distefano M, Filippini P, Riva A, Bombardelli E, Pocar D, Gelmi ML, Benedetti Panici P, Mancuso S. Anticancer Drug Des; 1998 Jan; 13(1):19-33. PubMed ID: 9474240 [Abstract] [Full Text] [Related]
2. Biological evaluation on different human cancer cell lines of novel colchicine analogs. De Vincenzo R, Ferlini C, Distefano M, Gaggini C, Riva A, Bombardelli E, Morazzoni P, Danieli B, Capelli G, Mancuso S, Scambia G. Oncol Res; 1999 Jan; 11(3):145-52. PubMed ID: 10527074 [Abstract] [Full Text] [Related]
3. Antitumor activity of paclitaxel (taxol) analogues on MDR-positive human cancer cells. Distefano M, Scambia G, Ferlini C, Gallo D, De Vincenzo R, Filippini P, Riva A, Bombardelli E, Mancuso S. Anticancer Drug Des; 1998 Jul; 13(5):489-99. PubMed ID: 9702212 [Abstract] [Full Text] [Related]
4. Molecular modes of action of cephalotaxine and homoharringtonine from the coniferous tree Cephalotaxus hainanensis in human tumor cell lines. Efferth T, Sauerbrey A, Halatsch ME, Ross DD, Gebhart E. Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):56-67. PubMed ID: 12616342 [Abstract] [Full Text] [Related]
5. The primary in vitro anticancer activity of "half-mustard type" phenothiazines in NCI's revised anticancer screening paradigm. Wuonola MA, Palfreyman MG, Motohashi N, Kawase M, Gabay S, Gupta RR, Molnár J. Anticancer Res; 1998 Jan; 18(1A):337-48. PubMed ID: 9568100 [Abstract] [Full Text] [Related]
6. MPC-6827: a small-molecule inhibitor of microtubule formation that is not a substrate for multidrug resistance pumps. Kasibhatla S, Baichwal V, Cai SX, Roth B, Skvortsova I, Skvortsov S, Lukas P, English NM, Sirisoma N, Drewe J, Pervin A, Tseng B, Carlson RO, Pleiman CM. Cancer Res; 2007 Jun 15; 67(12):5865-71. PubMed ID: 17575155 [Abstract] [Full Text] [Related]
13. Biological evaluation of 2,3-dichloro-5,8-dimethoxy-1,4-naphthoquinone as an anti-breast cancer agent. Kanaan YM, Das JR, Bakare O, Enwerem NM, Berhe S, Beyene D, Williams V, Zhou Y, Copeland RL. Anticancer Res; 2009 Jan 15; 29(1):191-9. PubMed ID: 19331150 [Abstract] [Full Text] [Related]
14. Tangeretin and nobiletin induce G1 cell cycle arrest but not apoptosis in human breast and colon cancer cells. Morley KL, Ferguson PJ, Koropatnick J. Cancer Lett; 2007 Jun 18; 251(1):168-78. PubMed ID: 17197076 [Abstract] [Full Text] [Related]
15. Identification and characterization of A-105972, an antineoplastic agent. Wu-Wong JR, Alder JD, Alder L, Burns DJ, Han EK, Credo B, Tahir SK, Dayton BD, Ewing PJ, Chiou WJ. Cancer Res; 2001 Feb 15; 61(4):1486-92. PubMed ID: 11245455 [Abstract] [Full Text] [Related]
16. Internalization of cytotoxic analog AN-152 of luteinizing hormone-releasing hormone induces apoptosis in human endometrial and ovarian cancer cell lines independent of multidrug resistance-1 (MDR-1) system. Günthert AR, Gründker C, Bongertz T, Schlott T, Nagy A, Schally AV, Emons G. Am J Obstet Gynecol; 2004 Oct 15; 191(4):1164-72. PubMed ID: 15507937 [Abstract] [Full Text] [Related]
20. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents. Romagnoli R, Baraldi PG, Pavani MG, Tabrizi MA, Preti D, Fruttarolo F, Piccagli L, Jung MK, Hamel E, Borgatti M, Gambari R. J Med Chem; 2006 Jun 29; 49(13):3906-15. PubMed ID: 16789746 [Abstract] [Full Text] [Related] Page: [Next] [New Search]